Skip to main content


Latest News

Media Highlight 02.27.24

Podcast: The Potential of a Functional Cure for HIV with Dr. Marc Conant of Addimmune

Read on Empowered Patient Podcast

Media Highlight 12.20.23

PM360 Online: 4 Biotech Executives Share Strategies Behind Successful Fund Raises

Read on PM360

Media Highlight 12.20.23

Sharetreck: Dr. Jeff Boyle, CSO - AGT talks about the current state of play of AGT 103-T

Read on ShareTreck

Media Highlight 12.14.23

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Read on Pharma's Almanac

Media Highlight 12.12.23

Cell and Gene: Imagine A World Without HIV – Could Gene Therapy Deliver A Cure?

Read on Cell & Gene

Media Highlight 12.02.23

Miami Beach: A hotspot for nightlife — and a hotspot for new HIV infections

Read on South Florida Sun Sentinel

Media Highlight 12.01.23

South Florida’s HIV dilemma: How to prevent babies from being born with the disease

Read on South Florida Sun Sentinel

Media Highlight 12.01.23

San Francisco Business Times: Pioneering HIV doctor talks about the early days of AIDS and his continuing push for a cure

Read on San Francisco Business Times

Media Highlight 11.27.23

Rockville biotech company aims to cure HIV

Read on MoCo360

Media Highlight 11.22.23

BioBuzz: How Two Former IT Industry Professionals Found Their Calling as Gene Therapy CEOs

Read on BioBuzz

BioBuzz: Be More Connected

Media Highlight 10.31.23

BioBuzz: Addimmune Prepares to go Public, Initiate Phase Ib HIV Trial

Read on BioBuzz

Press Release 10.11.23

American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportunities Conference

Read more

Media Highlight 10.08.23

Pharmashots: Addimmune to go Public via 10x Capital Venture Acquisition Corp. III SPAC Merger for ~$500M

Read on PharmaShots

Media Highlight 09.14.23

Lawstreet Media: Addimmune Goes Public in Bid to Cure HIV

Read on Law Street Media

Around The Helix with CGT Live

Media Highlight 08.16.23

Around the Helix: Cell and Gene Therapy Company Updates – August 16, 2023

Read on CGT Live

Media Highlight 08.10.23

BioPharma Dive: HIV cell therapy startup Addimmune heads to Wall Street via blank-check merger

Read on BioPharma Dive

Media Highlight 08.10.23

End Points News: HIV cell therapy biotech Addimmune to go public via SPAC merger; WHO names new Covid-19 'variant of interest'

Read on Endpoints News

a field of poppy flowers

Article 08.09.23

Introducing The Cure Chronicles Podcast

Read more

addimmune and 10x logos on a skyline.

Press Release 08.09.23

Addimmune to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

Read more

Article 08.03.23

The Geneva Patient: Another Case of HIV Remission

Read more

Media Highlight 07.19.23

Genetic Engineering & Biotechnology News: AGT Spins Out Addimmune, Focusing on Functional HIV Cure

Read on Genetic Engineering & Biotechnology News

Media Highlight 07.13.23

Precision Medicine Online: American Gene Technologies Spinoff Sets Sights on Advancing Cell Therapy for HIV

Read on Precision Medicine Online

Article 07.13.23

Perspectives on HIV: Viral Reservoirs

Read more

Media Highlight 07.11.23

CityBiz: Interview with Jeff Galvin, CEO & Founder of American Gene Technologies and Addimmune

Read on CityBiz

Article 07.11.23

Gene therapy for HIV: How does it work?

Read more

Media Highlight 06.30.23

Raif Derrazi Interviews Jeff Galvin on HIV Clinical Trial Updates & Addimmune 

Read on Raif Derrazi

Article 06.27.23

Gene Therapy and Lifeblood: Sickle Cell

Read more

Article 06.23.23

Challenge the narrative: HIV is a curable condition

Read more

Media Highlight 06.22.23

The Bay Area Reporter: Endowment Honors Pioneering HIV Doctor, Dr. Conant

Read on Bay Area Reporter

Media Highlight 06.22.23

ShareTreck: Jeff Galvin Weighs in on Addimmune’s Launch and AGT103-T Updates

Read on ShareTreck

Media Highlight 06.21.23

NBC4: Rockville Biotech Shares Encouraging News in HIV Fight

Read on NBC4 Washington

Media Highlight 06.21.23

DC News Now: Company Launches New Company “Addimmune” to Focus Exclusively on Developing Cure for HIV

Read on DC News Now

Media Highlight 06.21.23

WTOP: Rockville Gene Therapy Company Takes Next Step Toward HIV Cure

Read on WTOP News

Media Highlight 06.21.23

Washington Business Journal: Rockville’s AGT Launches Spinout Addimmune

Read on Washington Business Journal

Media Highlight 06.21.23

BioBuzz: American Gene Technologies Spins Off Addimmune as a Separate Company With a Focus on Curing HIV

Read on BioBuzz

Media Highlight 06.20.23

BioWorld: Addimmune Launches to Create a Functional Cure for HIV

Read on BioWorld

Media Highlight 06.20.23

MoCo 360: Rockville Biotech Company Sets Its Sights on Curing HIV

Read on MoCo360

Media Highlight 06.20.23

The Patch: Promising Data on Gene Cell Therapy for HIV Cure from Rockville Firm

Read on Patch

Media Highlight 06.20.23

My MC Media: Rockville Company Launches Spinoff Focused on Curing HIV

Read on My MC Media

Media Highlight 06.19.23

Morningside Maryland: Rockville Firm Reports Promising Data on Gene Cell Therapy for HIV Cure

Read on Morningside Maryland

Article 06.09.23

Our Sole Purpose Is to Cure HIV. We Are Addimmune™.

Read more

Article 05.23.23

Perspectives on HIV: Elite Controllers

Read more

How HIV treatments have evolved over time: a timeline of HIV medications

Article 04.26.23

Perspectives on HIV: Evolving Treatments

Read more

Why Hasn't HIV Been Cured Yet?

Article 04.10.23

Why Hasn’t HIV Been Cured Yet?

Read more

How treating Hepatitis C offers lessons for curing HIV

Article 03.06.23

The Road to an HIV Cure: Lessons from Hepatitis C

Read more

1rem 0 1 all hidden top 87.5% 0 1 .001 1.5 expo.out .1 .pinme false top 71 bottom bottom top center bottom bottom true 0 1 top center bottom bottom true 0 1 .navbar-inner false top top 99999px 0 none top -100 top -200 true play none none reverse 1 0 1px 3px 0 rgb(0 0 0 / 0.1), 0 1px 2px -1px rgb(0 0 0 / 0.1) none 1 true top 90% 0 2 .25 .001 power4.out